Skip to content

Strong Hearts: A Remote, App-Enabled, Exercise Program for Patients With Congenital Heart Disease (Strong Hearts App)

Strong Hearts: A Remote, App-Enabled, Exercise Program for Patients With Congenital Heart Disease

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05853705
Enrollment
9
Registered
2023-05-11
Start date
2024-01-12
Completion date
2024-12-05
Last updated
2026-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease

Keywords

Child, Adult

Brief summary

The overall goal of this program is to create a remote, mobile application enabled exercise program for patients with Congenital Heart Disease (CHD). Pilot trials will consist of a remote exercise program with app-embedded exercise modules designed to promote and encourage safe and healthy exercise habits across a range of CHD anatomies. This app-enabled program will allow for real time data collection integrating wearable devices, as well as compliance and safety monitoring to enhance research capabilities. The app-enabled program will be versatile and may be applied in the future to patients with non-cardiac conditions.

Interventions

BEHAVIORALStrong Hearts Exercise Program

The participant will either begin at the easiest variation of each strength exercise (level A), or will be placed at a specific level for each strength exercise based on their assessment with physical therapy. Participants can progress to the next level of difficulty of a specific strength exercise based on their rating of perceived exertion (RPE) with the opportunity to move to the next level if they have RPE score of 6 or less and if their heart rates are at goal. Each participant will be provided with heart rate ranges based on the heart rate reserve (HRR) method using their baseline resting and peak heart rates obtained during their cardiopulmonary exercise testing (CPET) or percent predicted heart rate based on age if CPET is not available. HRR goals will be set individually for patients and adjusted per protocol to guide effort.

Sponsors

Duke University
Lead SponsorOTHER
Food and Drug Administration (FDA)
CollaboratorFED

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Repaired or unrepaired Congenital Heart Disease (CHD) * Between ages 10 and 50, inclusive, at time of consent * Android or Apple smartphone that meets the operating systems below with the ability to download applications from either Google Play or the Apple store * Android: 6.0 or higher * Apple: iPhone Operating System (iOS) 13 or higher

Exclusion criteria

* Physical or mental disabilities preventing exercise participation * Uncontrolled systemic hypertension (symptomatic or greater than Stage 2 hypertension while on therapy) * Poorly controlled arrhythmia * Clinically unstable heart failure * Known pregnancy at the time of enrollment

Design outcomes

Primary

MeasureTime frame
Change in peak rate of oxygen volume consumption (VO2) on Cardiopulmonary Exercise TestingBaseline, up to 12 weeks

Secondary

MeasureTime frameDescription
Change in Pediatric Cardiac Quality of Life Inventory1 yearThe Pediatric Cardiac Quality of Life Inventory generates 3 scores (total, disease impact subscale, and psychosocial impact subscale). Each subscale has a maximum of 50 points and their sums yields the total score. Higher scores indicate better perceived health-related quality of life.
Change in Short Form 36 (SF-36) Health Survey1 yearThe Short Form 36 Health Survey consists of 8 subscales (physical functioning, role limitations due to physical health, role limitations due to emotional problems, energy/fatigue, emotional well-being, social functioning, pain, and general health). The survey will be scored using the two step RAND scoring process. The first step scores each question on a scale from 0 (worst) to 100 (best) and represents the percentage of total possible score achieved. The second scoring step, takes the average of all the questions in each subscale to create the 8 scores.
Change in sit-to-stand testBaseline, up to 12 weeks
Change in secondary Cardiopulmonary Exercise Testing outcome measuresBaseline, up to 12 weeks

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORReid C Chamberlain, MD, MSCI

Duke UMC

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 6, 2026